Estimation of non-high-density lipoprotein cholesterol and its correlation as a surrogate measure of apolipoprotein B in patients with metabolic syndrome

Background: The primary target of therapy for dyslipidemia according to the present lipid guidelines is low-density lipoprotein cholesterol (LDL-C). Its main drawback is it is a derived value and erroneous values may be obtained if triglyceride values are high. Hence, direct measurement of apolipopr...

Descripción completa

Detalles Bibliográficos

Autores principales:	K G Prakash, B Sumana, Abhiman B Shetty
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Wolters Kluwer Medknow Publications 2020-01-01
Colección:	APIK Journal of Internal Medicine
Materias:	apolipoprotein b-100 dyslipidemia metabolic syndrome non-high-density lipoprotein cholesterol
Acceso en línea:	http://www.ajim.in/article.asp?issn=2666-1802;year=2020;volume=8;issue=2;spage=60;epage=64;aulast=Prakash
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!